Dana Filoti

AbbVie, Inc.

Dana Filoti is currently leading the Research and Early Developability analytical group, within the Analytical R&D Department at AbbVie. She has received her Ph.D. in Materials Science from the University of New Hampshire and Bachelor's degree in Physics from the University of Bucharest. She worked as a Post-Doctoral fellow at the Biomolecular Interaction Technologies Center (BITC) on the development of instrumentation and methods for examining macromolecular interactions via charge measurements. Her research focuses on demystifying chemical and colloidal stability issues associated with pharmaceutically relevant biomolecules at high concentration. She has experience in ADCs and IgG-based biologics developability assessment and formulation, analytical development and biophysical characterization.